Juvena Therapeutics: Valuation, Funding & Investors
Juvena Therapeutics is a clinical-stage biotechnology company developing AI-enabled regenerative biologics designed to restore tissue function. The company is advancing a pipeline targeting neuromuscular and age-related diseases by translating insights from human biology into engineered therapeutics.
Leadership & Board
- Current Number of Employees
- 42
- Current LinkedIn Followers
- 10,681
Latest Estimated Valuation
- Total Amount Raised
- $34M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $34M
- Latest Funding Round
- Series B
Employee Trend
Juvena Therapeutics had 42 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
42Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Juvena Therapeutics had 10,681 followers as of November 2, 2026. The number of followers increased by 12 (0.11%) week-over-week.
10,681Latest Followers Count
12(0.11%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 12, 2026 | Series B | $33.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Eli Lilly and Company | Series B |
| Mubadala Capital | Series B |
| Bison Ventures | Series B |
| Jefferson Life Sciences | Series B |
| Manta Ray | Series B |
Similar Companies
A snapshot of private companies similar to Juvena Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
